(20S)-ginsenoside Rg3 decreases expression ISO RGD:1350605 6480464 ginsenoside Rg3 results in decreased expression of POU5F1 mRNA CTD PMID:31916386 (S)-nicotine multiple interactions ISO RGD:1552733 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of POU5F1 mRNA] CTD PMID:15749260 (S)-nicotine multiple interactions ISO RGD:1350605 6480464 SNAI1 mutant form inhibits the reaction [Nicotine results in increased expression of POU5F1 mRNA] CTD PMID:23219715 (S)-nicotine increases expression ISO RGD:1350605 6480464 Nicotine results in increased expression of POU5F1 mRNA, Nicotine results in increased expression of POU5F1 protein CTD PMID:23219715 (S)-nicotine increases expression ISO RGD:1552733 6480464 Nicotine results in increased expression of POU5F1 mRNA CTD PMID:15612475 , PMID:15749260 1,7-phenanthroline decreases expression ISO RGD:1552733 6480464 1, 7-phenanthroline results in decreased expression of POU5F1 protein CTD PMID:21111795 1-methyltryptophan multiple interactions ISO RGD:1350605 6480464 1-methyltryptophan inhibits the reaction [indeno(1 more ... CTD PMID:35687267 17beta-estradiol multiple interactions ISO RGD:1350605 6480464 [Arsenic co-treated with Estradiol] results in increased expression of POU5F1 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol increases expression ISO RGD:1552733 6480464 Estradiol results in increased expression of POU5F1 mRNA CTD PMID:20615461 17beta-estradiol increases expression ISO RGD:1350605 6480464 Estradiol results in increased expression of POU5F1 mRNA, Estradiol results in increased expression of POU5F1 protein CTD PMID:22132214 more ... 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1552733 6480464 2 more ... CTD PMID:34547414 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1552733 6480464 Tetrachlorodibenzodioxin results in decreased expression of POU5F1 mRNA, Tetrachlorodibenzodioxin results in decreased expression of POU5F1 protein CTD PMID:24058054 , PMID:32283119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552733 6480464 Tetrachlorodibenzodioxin affects the expression of POU5F1 mRNA, Tetrachlorodibenzodioxin affects the expression of POU5F1 protein CTD PMID:36029422 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1350605 6480464 Tetrachlorodibenzodioxin results in increased expression of POU5F1 mRNA CTD PMID:22132214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1350605 6480464 Metformin inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to POU5F1 promoter]], Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to POU5F1 promoter] CTD PMID:22132214 2,4-di-tert-butylphenol multiple interactions ISO RGD:1350605 6480464 [Chir 99021 co-treated with 2, 4-di-tert-butylphenol] results in increased expression of POU5F1 mRNA CTD PMID:36682590 2,6-dimethyl-4-tridecylmorpholine increases expression ISO RGD:1552733 6480464 tridemorph results in increased expression of POU5F1 mRNA CTD PMID:34737147 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO RGD:1350605 6480464 [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 mRNA, [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 protein CTD PMID:35063459 2-methoxy-17beta-estradiol multiple interactions ISO RGD:1552733 6480464 2-Methoxyestradiol inhibits the reaction [Curcumin results in increased expression of POU5F1 mRNA] CTD PMID:25822711 3,5,6-trichloro-2-pyridinol increases expression ISO RGD:1552733 6480464 3 more ... CTD PMID:23220036 3,5,6-trichloropyridine-2-one increases expression ISO RGD:1552733 6480464 3 more ... CTD PMID:23220036 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the expression of POU5F1 mRNA CTD PMID:21350315 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1350605 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POU5F1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POU5F1 mRNA CTD PMID:28628672 3-methyladenine increases expression ISO RGD:1552733 6480464 3-methyladenine results in increased expression of POU5F1 protein CTD PMID:21681844 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1350605 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POU5F1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1552733 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of POU5F1 promoter CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:1350605 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of POU5F1 mRNA CTD PMID:36565802 4-nonylphenol increases expression ISO RGD:1552733 6480464 4-nonylphenol results in increased expression of POU5F1 mRNA CTD PMID:20615461 4-tert-Octylphenol increases expression ISO RGD:1552733 6480464 4-tert-octylphenol results in increased expression of POU5F1 mRNA CTD PMID:20615461 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1350605 6480464 trichostatin A promotes the reaction [Decitabine affects the expression of POU5F1 mRNA] CTD PMID:18440631 5-fluorouracil decreases expression ISO RGD:1552733 6480464 Fluorouracil results in decreased expression of POU5F1 protein CTD PMID:21296659 5-fluorouracil decreases expression ISO RGD:1350605 6480464 Fluorouracil results in decreased expression of POU5F1 mRNA CTD PMID:24737281 5-hydroxytryptophan decreases expression ISO RGD:1552733 6480464 5-Hydroxytryptophan results in decreased expression of POU5F1 mRNA CTD PMID:32926198 6-bromoindirubin-3'-oxime multiple interactions ISO RGD:1552733 6480464 [Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of POU5F1 mRNA CTD PMID:27693483 acetic acid decreases expression ISO RGD:1552733 6480464 Acetic Acid results in decreased expression of POU5F1 protein CTD PMID:21296659 acrylamide increases expression ISO RGD:1552733 6480464 Acrylamide results in increased expression of POU5F1 mRNA CTD PMID:36599426 afatinib decreases expression ISO RGD:1350605 6480464 afatinib results in decreased expression of POU5F1 protein CTD PMID:28787001 afatinib multiple interactions ISO RGD:1350605 6480464 afatinib inhibits the reaction [EGF protein results in increased expression of POU5F1 protein] CTD PMID:28787001 aldehydo-D-glucose affects localization ISO RGD:1350605 6480464 Glucose affects the localization of POU5F1 protein CTD PMID:33992720 all-trans-retinoic acid multiple interactions ISO RGD:1552733 6480464 AGN 193109 inhibits the reaction [Tretinoin results in decreased expression of POU5F1 mRNA] more ... CTD PMID:16166633 more ... all-trans-retinoic acid affects expression ISO RGD:1350605 6480464 Tretinoin affects the expression of POU5F1 mRNA CTD PMID:31600526 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of POU5F1 mRNA CTD PMID:30476341 all-trans-retinoic acid decreases expression ISO RGD:1350605 6480464 Tretinoin results in decreased expression of POU5F1 mRNA, Tretinoin results in decreased expression of POU5F1 protein CTD PMID:16168501 more ... all-trans-retinoic acid increases expression ISO RGD:1552733 6480464 Tretinoin results in increased expression of POU5F1 protein CTD PMID:30442713 all-trans-retinoic acid decreases expression ISO RGD:1552733 6480464 Tretinoin results in decreased expression of POU5F1 mRNA, Tretinoin results in decreased expression of POU5F1 protein CTD PMID:16415856 more ... all-trans-retinoic acid increases methylation ISO RGD:1552733 6480464 Tretinoin results in increased methylation of POU5F1 promoter CTD PMID:16415856 apigenin decreases expression ISO RGD:1350605 6480464 Apigenin results in decreased expression of POU5F1 protein CTD PMID:22906706 Arg-Gly-Asp decreases expression ISO RGD:1350605 6480464 arginyl-glycyl-aspartic acid results in decreased expression of POU5F1 protein CTD PMID:37027338 aristolochic acid A increases expression ISO RGD:1350605 6480464 aristolochic acid I results in increased expression of POU5F1 mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO RGD:1350605 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane affects methylation ISO RGD:1350605 6480464 Arsenic affects the methylation of POU5F1 gene CTD PMID:25304211 arsane increases expression ISO RGD:1552733 6480464 Arsenic results in increased expression of POU5F1 mRNA CTD PMID:33124703 arsane multiple interactions ISO RGD:1350605 6480464 [Arsenic co-treated with Estradiol] results in increased expression of POU5F1 mRNA CTD PMID:33047385 arsenic atom affects methylation ISO RGD:1350605 6480464 Arsenic affects the methylation of POU5F1 gene CTD PMID:25304211 arsenic atom increases expression ISO RGD:1552733 6480464 Arsenic results in increased expression of POU5F1 mRNA CTD PMID:33124703 arsenic atom multiple interactions ISO RGD:1350605 6480464 [Arsenic co-treated with Estradiol] results in increased expression of POU5F1 mRNA CTD PMID:33047385 arsenite(3-) increases expression ISO RGD:1350605 6480464 arsenite results in increased expression of POU5F1 mRNA CTD PMID:22447124 arsenous acid decreases expression ISO RGD:1552733 6480464 Arsenic Trioxide results in decreased expression of POU5F1 mRNA, Arsenic Trioxide results in decreased expression of POU5F1 protein CTD PMID:29767511 arsenous acid decreases expression ISO RGD:1350605 6480464 Arsenic Trioxide results in decreased expression of POU5F1 mRNA CTD PMID:33634982 arsenous acid multiple interactions ISO RGD:1350605 6480464 Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein] more ... CTD PMID:29396848 , PMID:29486283 arsenous acid multiple interactions ISO RGD:1552733 6480464 [Arsenic Trioxide co-treated with FN1 protein] results in decreased expression of POU5F1 mRNA CTD PMID:22641096 arsenous acid increases expression ISO RGD:1350605 6480464 Arsenic Trioxide results in increased expression of POU5F1 mRNA, Arsenic Trioxide results in increased expression of POU5F1 protein CTD PMID:29396848 , PMID:29486283 aspartame affects localization ISO RGD:1350605 6480464 Aspartame affects the localization of POU5F1 protein CTD PMID:33992720 atrazine increases expression ISO RGD:1350605 6480464 Atrazine results in increased expression of POU5F1 mRNA CTD PMID:34146662 belinostat increases expression ISO RGD:1350605 6480464 belinostat results in increased expression of POU5F1 mRNA CTD PMID:26272509 benzo[a]pyrene increases methylation ISO RGD:1350605 6480464 Benzo(a)pyrene results in increased methylation of POU5F1 exon CTD PMID:27901495 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1350605 6480464 Diethylhexyl Phthalate inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1350605 6480464 Diethylhexyl Phthalate results in increased expression of POU5F1 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1552733 6480464 Diethylhexyl Phthalate results in increased expression of POU5F1 mRNA CTD PMID:28123099 , PMID:28286118 bisphenol A increases expression ISO RGD:1552733 6480464 bisphenol A results in increased expression of POU5F1 mRNA, bisphenol A results in increased expression of POU5F1 protein CTD PMID:23719110 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Streptozocin] results in decreased expression of POU5F1 protein CTD PMID:35187753 bisphenol A decreases expression ISO RGD:1552733 6480464 bisphenol A results in decreased expression of POU5F1 mRNA CTD PMID:35219798 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of POU5F1 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1350605 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POU5F1 mRNA more ... CTD PMID:27551335 more ... bisphenol A affects methylation ISO RGD:1552733 6480464 bisphenol A affects the methylation of POU5F1 promoter CTD PMID:27334623 bisphenol A increases expression ISO RGD:1350605 6480464 bisphenol A results in increased expression of POU5F1 mRNA, bisphenol A results in increased expression of POU5F1 protein CTD PMID:23391485 , PMID:27551335 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of POU5F1 mRNA CTD PMID:25181051 bromochloroacetic acid increases expression ISO RGD:1552733 6480464 bromochloroacetic acid results in increased expression of POU5F1 protein CTD PMID:21296659 bucladesine affects expression ISO RGD:1350605 6480464 Bucladesine affects the expression of POU5F1 mRNA, Bucladesine affects the expression of POU5F1 protein CTD PMID:31400064 bucladesine multiple interactions ISO RGD:1350605 6480464 bisphenol A affects the reaction [Bucladesine affects the expression of POU5F1 mRNA] more ... CTD PMID:31400064 butanal decreases expression ISO RGD:1350605 6480464 butyraldehyde results in decreased expression of POU5F1 mRNA CTD PMID:26079696 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of POU5F1 promoter CTD PMID:22457795 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of POU5F1 gene CTD PMID:30521419 carbaryl multiple interactions ISO RGD:1350605 6480464 Carbaryl promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 carbon nanotube decreases expression ISO RGD:1350605 6480464 Nanotubes, Carbon results in decreased expression of POU5F1 mRNA CTD PMID:23634900 casticin multiple interactions ISO RGD:1350605 6480464 casticin promotes the reaction [MIR148A mRNA results in decreased expression of POU5F1 mRNA] more ... CTD PMID:32268151 casticin decreases expression ISO RGD:1350605 6480464 casticin results in decreased expression of POU5F1 mRNA CTD PMID:32268151 CHIR 99021 decreases expression ISO RGD:1350605 6480464 Chir 99021 results in decreased expression of POU5F1 mRNA CTD PMID:31711903 CHIR 99021 multiple interactions ISO RGD:1350605 6480464 [4-(2-(5 more ... CTD PMID:34480604 , PMID:36682590 chlordecone decreases expression ISO RGD:1350605 6480464 Chlordecone results in decreased expression of POU5F1 protein CTD PMID:22906706 chlordecone affects expression ISO RGD:1552733 6480464 Chlordecone affects the expression of POU5F1 mRNA CTD PMID:29980752 chlorpromazine decreases expression ISO RGD:1350605 6480464 Chlorpromazine results in decreased expression of POU5F1 mRNA CTD PMID:30703373 chlorpyrifos decreases expression ISO RGD:1552733 6480464 Chlorpyrifos results in decreased expression of POU5F1 mRNA CTD PMID:23220036 , PMID:36769379 chlorpyrifos increases expression ISO RGD:1552733 6480464 Chlorpyrifos results in increased expression of POU5F1 mRNA CTD PMID:32715474 chromium(6+) increases expression ISO RGD:1552733 6480464 chromium hexavalent ion results in increased expression of POU5F1 mRNA CTD PMID:19654923 chromium(6+) multiple interactions ISO RGD:1552733 6480464 MAP2K7 protein promotes the reaction [chromium hexavalent ion results in increased expression of POU5F1 mRNA] CTD PMID:19654923 ciprofloxacin increases expression ISO RGD:1350605 6480464 Ciprofloxacin results in increased expression of POU5F1 protein CTD PMID:26947806 cisplatin multiple interactions ISO RGD:1350605 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of POU5F1 mRNA more ... CTD PMID:20705681 more ... cisplatin increases expression ISO RGD:1350605 6480464 Cisplatin results in increased expression of POU5F1 mRNA, Cisplatin results in increased expression of POU5F1 protein CTD PMID:20074550 more ... clofibrate increases expression ISO RGD:1552733 6480464 Clofibrate results in increased expression of POU5F1 mRNA CTD PMID:17585979 cobalt atom multiple interactions ISO RGD:1350605 6480464 Ascorbic Acid inhibits the reaction [Cobalt results in increased expression of POU5F1 protein] more ... CTD PMID:24497960 cobalt dichloride multiple interactions ISO RGD:1350605 6480464 [EPAS1 protein results in increased susceptibility to cobaltous chloride] which results in increased expression of POU5F1 mRNA, [HIF1A protein results in increased susceptibility to cobaltous chloride] which results in increased expression of POU5F1 mRNA CTD PMID:25805230 cortisol multiple interactions ISO RGD:1350605 6480464 [4-(2-(5 more ... CTD PMID:34480604 curcumin multiple interactions ISO RGD:1552733 6480464 2-methoxyestradiol inhibits the reaction [Curcumin results in increased expression of POU5F1 mRNA] CTD PMID:25822711 curcumin decreases expression ISO RGD:1350605 6480464 Curcumin results in decreased expression of POU5F1 mRNA, Curcumin results in decreased expression of POU5F1 protein CTD PMID:33539684 curcumin multiple interactions ISO RGD:1350605 6480464 WWTR1 protein inhibits the reaction [Curcumin results in decreased expression of POU5F1 mRNA], WWTR1 protein inhibits the reaction [Curcumin results in decreased expression of POU5F1 protein] CTD PMID:33539684 curcumin increases expression ISO RGD:1552733 6480464 Curcumin results in increased expression of POU5F1 mRNA, Curcumin results in increased expression of POU5F1 protein CTD PMID:25822711 , PMID:27237783 cycloheximide multiple interactions ISO RGD:1350605 6480464 Cycloheximide promotes the reaction [Cobalt results in increased expression of POU5F1 protein], Cycloheximide promotes the reaction [nickel chloride results in increased expression of POU5F1 protein] CTD PMID:24497960 cypermethrin increases expression ISO RGD:1552733 6480464 cypermethrin results in increased expression of POU5F1 mRNA CTD PMID:32214279 D-glucose affects localization ISO RGD:1350605 6480464 Glucose affects the localization of POU5F1 protein CTD PMID:33992720 DDT multiple interactions ISO RGD:1350605 6480464 DDT inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 decabromodiphenyl ether multiple interactions ISO RGD:1350605 6480464 Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in decreased expression of POU5F1 protein] CTD PMID:26206603 decabromodiphenyl ether decreases expression ISO RGD:1350605 6480464 decabromobiphenyl ether results in decreased expression of POU5F1 mRNA, decabromobiphenyl ether results in decreased expression of POU5F1 protein CTD PMID:26206603 decabromodiphenyl ether increases methylation ISO RGD:1350605 6480464 decabromobiphenyl ether results in increased methylation of POU5F1 promoter CTD PMID:26206603 deoxycholic acid increases expression ISO RGD:1552733 6480464 Deoxycholic Acid results in increased expression of POU5F1 mRNA CTD PMID:27151938 desferrioxamine B increases expression ISO RGD:1350605 6480464 Deferoxamine results in increased expression of POU5F1 mRNA CTD PMID:22447124 dexamethasone multiple interactions EXP 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the expression of POU5F1 mRNA CTD PMID:21350315 dexamethasone multiple interactions ISO RGD:1552733 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of POU5F1 mRNA CTD PMID:28189605 dexamethasone multiple interactions ISO RGD:1350605 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POU5F1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POU5F1 mRNA CTD PMID:28628672 diallyl trisulfide multiple interactions ISO RGD:1350605 6480464 [diallyl trisulfide results in increased abundance of Hydrogen Sulfide] which results in increased expression of POU5F1 mRNA CTD PMID:33180827 diarsenic trioxide increases expression ISO RGD:1350605 6480464 Arsenic Trioxide results in increased expression of POU5F1 mRNA, Arsenic Trioxide results in increased expression of POU5F1 protein CTD PMID:29396848 , PMID:29486283 diarsenic trioxide decreases expression ISO RGD:1350605 6480464 Arsenic Trioxide results in decreased expression of POU5F1 mRNA CTD PMID:33634982 diarsenic trioxide multiple interactions ISO RGD:1552733 6480464 [Arsenic Trioxide co-treated with FN1 protein] results in decreased expression of POU5F1 mRNA CTD PMID:22641096 diarsenic trioxide multiple interactions ISO RGD:1350605 6480464 Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein] more ... CTD PMID:29396848 , PMID:29486283 diarsenic trioxide decreases expression ISO RGD:1552733 6480464 Arsenic Trioxide results in decreased expression of POU5F1 mRNA, Arsenic Trioxide results in decreased expression of POU5F1 protein CTD PMID:29767511 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of POU5F1 protein CTD PMID:16916955 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of POU5F1 mRNA CTD PMID:31050326 dieldrin multiple interactions ISO RGD:1350605 6480464 Dieldrin promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 diethyl maleate increases expression ISO RGD:1350605 6480464 diethyl maleate results in increased expression of POU5F1 mRNA CTD PMID:33545341 dimethyl sulfoxide affects expression ISO RGD:1350605 6480464 Dimethyl Sulfoxide affects the expression of POU5F1 mRNA CTD PMID:24834073 dioxygen decreases expression ISO RGD:1552733 6480464 Oxygen deficiency results in decreased expression of POU5F1 mRNA CTD PMID:16814746 dioxygen increases expression ISO RGD:1350605 6480464 Oxygen deficiency results in increased expression of POU5F1 protein CTD PMID:23725749 entinostat increases expression ISO RGD:1350605 6480464 entinostat results in increased expression of POU5F1 mRNA CTD PMID:26272509 ethanol multiple interactions ISO RGD:1350605 6480464 HBEGF protein inhibits the reaction [Ethanol results in decreased expression of POU5F1 protein] CTD PMID:19919524 ethanol increases expression EXP 6480464 Ethanol results in increased expression of POU5F1 mRNA, Ethanol results in increased expression of POU5F1 protein CTD PMID:29769550 ethanol increases expression ISO RGD:1350605 6480464 Ethanol results in increased expression of POU5F1 mRNA CTD PMID:23378141 ethanol decreases expression ISO RGD:1350605 6480464 Ethanol results in decreased expression of POU5F1 protein CTD PMID:19919524 etoposide increases expression ISO RGD:1350605 6480464 Etoposide results in increased expression of POU5F1 mRNA, Etoposide results in increased expression of POU5F1 protein CTD PMID:33969609 eugenol decreases expression ISO RGD:1552733 6480464 Eugenol results in decreased expression of POU5F1 protein CTD PMID:31926151 eugenol decreases expression ISO RGD:1350605 6480464 Eugenol results in decreased expression of POU5F1 mRNA, Eugenol results in decreased expression of POU5F1 protein CTD PMID:31926151 fluoxetine affects expression ISO RGD:1552733 6480464 Fluoxetine affects the expression of POU5F1 mRNA CTD PMID:29893963 fulvestrant multiple interactions ISO RGD:1350605 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of POU5F1 mRNA] CTD PMID:22132214 gemcitabine decreases expression ISO RGD:1350605 6480464 Gemcitabine results in decreased expression of POU5F1 mRNA CTD PMID:35063459 genistein decreases expression ISO RGD:1552733 6480464 Genistein results in decreased expression of POU5F1 mRNA CTD PMID:32186404 glucose affects localization ISO RGD:1350605 6480464 Glucose affects the localization of POU5F1 protein CTD PMID:33992720 glycerol 2-phosphate multiple interactions ISO RGD:1552733 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of POU5F1 mRNA CTD PMID:28189605 GW 3965 multiple interactions ISO RGD:1350605 6480464 GW 3965 inhibits the reaction [NR1H2 protein results in increased expression of POU5F1 mRNA] CTD PMID:31932555 GW 3965 decreases expression ISO RGD:1350605 6480464 GW 3965 results in decreased expression of POU5F1 protein CTD PMID:31932555 GW 4064 decreases expression ISO RGD:1350605 6480464 GW 4064 results in decreased expression of POU5F1 protein CTD PMID:31932555 heptachlor multiple interactions ISO RGD:1350605 6480464 Heptachlor inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 hexachlorophene multiple interactions ISO RGD:1350605 6480464 Hexachlorophene inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 hydrogen peroxide affects expression ISO RGD:1350605 6480464 Hydrogen Peroxide affects the expression of POU5F1 mRNA CTD PMID:20044591 hydrogen sulfide multiple interactions ISO RGD:1350605 6480464 [diallyl trisulfide results in increased abundance of Hydrogen Sulfide] which results in increased expression of POU5F1 mRNA, [sodium bisulfide results in increased abundance of Hydrogen Sulfide] which results in increased expression of POU5F1 mRNA CTD PMID:33180827 ibuprofen decreases expression ISO RGD:1350605 6480464 Ibuprofen results in decreased expression of POU5F1 mRNA CTD PMID:29665328 Indeno[1,2,3-cd]pyrene increases expression ISO RGD:1350605 6480464 indeno(1 more ... CTD PMID:35687267 Indeno[1,2,3-cd]pyrene multiple interactions ISO RGD:1350605 6480464 1-methyltryptophan inhibits the reaction [indeno(1 more ... CTD PMID:35687267 indinavir multiple interactions ISO RGD:1552733 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of POU5F1 mRNA CTD PMID:16931933 indometacin multiple interactions ISO RGD:1350605 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POU5F1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POU5F1 mRNA CTD PMID:28628672 isoorientin decreases expression ISO RGD:1350605 6480464 homoorientin results in decreased expression of POU5F1 protein CTD PMID:34019859 ivermectin decreases expression ISO RGD:1350605 6480464 Ivermectin results in decreased expression of POU5F1 mRNA, Ivermectin results in decreased expression of POU5F1 protein CTD PMID:29257278 kaempferol decreases expression ISO RGD:1350605 6480464 kaempferol results in decreased expression of POU5F1 mRNA, kaempferol results in decreased expression of POU5F1 protein CTD PMID:22906706 , PMID:35063459 kaempferol multiple interactions ISO RGD:1350605 6480464 [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 mRNA, [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 protein CTD PMID:35063459 kaempferol increases expression ISO RGD:1552733 6480464 kaempferol results in increased expression of POU5F1 protein CTD PMID:26683311 ketoconazole decreases expression ISO RGD:1552733 6480464 Ketoconazole results in decreased expression of POU5F1 mRNA CTD PMID:16574651 L-ascorbic acid increases expression ISO RGD:1350605 6480464 Ascorbic Acid results in increased expression of POU5F1 mRNA CTD PMID:21166886 L-ascorbic acid multiple interactions ISO RGD:1552733 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of POU5F1 mRNA CTD PMID:28189605 L-ascorbic acid multiple interactions ISO RGD:1350605 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mRNA, Ascorbic Acid inhibits the reaction [Cobalt results in increased expression of POU5F1 protein] CTD PMID:24497960 , PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:1350605 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mRNA CTD PMID:34480604 lamivudine multiple interactions ISO RGD:1552733 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of POU5F1 mRNA more ... CTD PMID:16931933 lead diacetate increases expression ISO RGD:1552733 6480464 lead acetate results in increased expression of POU5F1 mRNA CTD PMID:31715224 lead(0) increases expression ISO RGD:1350605 6480464 Lead results in increased expression of POU5F1 protein CTD PMID:25193092 leflunomide decreases expression ISO RGD:1350605 6480464 leflunomide results in decreased expression of POU5F1 mRNA CTD PMID:28988120 lithium chloride multiple interactions ISO RGD:1350605 6480464 CTNNB1 protein promotes the reaction [Lithium Chloride results in increased expression of POU5F1 mRNA] more ... CTD PMID:20069066 , PMID:20074550 lithium chloride increases expression ISO RGD:1350605 6480464 Lithium Chloride results in increased expression of POU5F1 mRNA, Lithium Chloride results in increased expression of POU5F1 protein CTD PMID:20069066 , PMID:20074550 lupeol decreases expression ISO RGD:1552733 6480464 lupeol results in decreased expression of POU5F1 protein CTD PMID:20979057 LY294002 multiple interactions ISO RGD:1552733 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with sodium arsenite] results in decreased expression of POU5F1 protein CTD PMID:23143138 LY294002 decreases expression ISO RGD:1552733 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of POU5F1 protein CTD PMID:23143138 melatonin multiple interactions ISO RGD:1350605 6480464 Melatonin inhibits the reaction [bisphenol A promotes the reaction [ESR1 protein binds to POU5F1 promoter]] more ... CTD PMID:27551335 melatonin decreases expression ISO RGD:1350605 6480464 Melatonin results in decreased expression of POU5F1 mRNA, Melatonin results in decreased expression of POU5F1 protein CTD PMID:27551335 metformin multiple interactions ISO RGD:1350605 6480464 Metformin inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to POU5F1 promoter]], Metformin inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to POU5F1 promoter]] CTD PMID:22132214 methamphetamine affects response to substance ISO RGD:1350605 6480464 POU5F1 gene SNP affects the susceptibility to Methamphetamine CTD PMID:18316681 methylmercury chloride increases expression ISO RGD:1350605 6480464 methylmercuric chloride results in increased expression of POU5F1 mRNA, methylmercuric chloride results in increased expression of POU5F1 protein CTD PMID:22555245 more ... methylparaben increases expression ISO RGD:1350605 6480464 methylparaben results in increased expression of POU5F1 mRNA CTD PMID:27581495 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of POU5F1 mRNA CTD PMID:30476341 N-acetyl-L-cysteine multiple interactions ISO RGD:1350605 6480464 Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in decreased expression of POU5F1 protein], Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of POU5F1 protein] CTD PMID:26206603 , PMID:32745510 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1350605 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of POU5F1 protein CTD PMID:24497960 N-nitrosodiethylamine multiple interactions ISO RGD:1552733 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of POU5F1 gene CTD PMID:23968726 nickel dichloride increases expression ISO RGD:1350605 6480464 nickel chloride results in increased expression of POU5F1 protein CTD PMID:26962057 nickel dichloride multiple interactions ISO RGD:1350605 6480464 Cycloheximide promotes the reaction [nickel chloride results in increased expression of POU5F1 protein], nickel chloride results in increased expression of and results in increased stability of POU5F1 protein CTD PMID:24497960 niclosamide decreases phosphorylation ISO RGD:1350605 6480464 Niclosamide results in decreased phosphorylation of POU5F1 protein CTD PMID:23333246 nicotine multiple interactions ISO RGD:1552733 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of POU5F1 mRNA] CTD PMID:15749260 nicotine increases expression ISO RGD:1350605 6480464 Nicotine results in increased expression of POU5F1 mRNA, Nicotine results in increased expression of POU5F1 protein CTD PMID:23219715 nicotine increases expression ISO RGD:1552733 6480464 Nicotine results in increased expression of POU5F1 mRNA CTD PMID:15612475 , PMID:15749260 nicotine multiple interactions ISO RGD:1350605 6480464 SNAI1 mutant form inhibits the reaction [Nicotine results in increased expression of POU5F1 mRNA] CTD PMID:23219715 nocodazole decreases expression ISO RGD:1350605 6480464 Nocodazole results in decreased expression of POU5F1 protein CTD PMID:21559451 Nonylphenol increases expression ISO RGD:1552733 6480464 nonylphenol results in increased expression of POU5F1 mRNA CTD PMID:31288075 Octicizer decreases expression ISO RGD:1350605 6480464 2-ethylhexyldiphenylphosphate results in decreased expression of POU5F1 protein CTD PMID:37027338 p-tert-Amylphenol increases expression ISO RGD:1552733 6480464 4-tert-octylphenol results in increased expression of POU5F1 mRNA CTD PMID:20615461 paclitaxel multiple interactions ISO RGD:1350605 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of POU5F1 mRNA, [Cisplatin co-treated with Paclitaxel] results in increased expression of POU5F1 protein CTD PMID:20705681 panobinostat increases expression ISO RGD:1350605 6480464 panobinostat results in increased expression of POU5F1 mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:1552733 6480464 Acetaminophen results in decreased expression of POU5F1 mRNA CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of POU5F1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1350605 6480464 Acetaminophen results in decreased expression of POU5F1 mRNA CTD PMID:29067470 paraquat increases expression ISO RGD:1350605 6480464 Paraquat results in increased expression of POU5F1 mRNA, Paraquat results in increased expression of POU5F1 protein CTD PMID:30698896 paraquat decreases expression ISO RGD:1552733 6480464 Paraquat results in decreased expression of POU5F1 protein CTD PMID:35511227 paraquat multiple interactions ISO RGD:1350605 6480464 Paraquat affects the reaction [Bucladesine affects the expression of POU5F1 mRNA], Paraquat affects the reaction [Bucladesine affects the expression of POU5F1 protein] CTD PMID:31400064 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1552733 6480464 perfluorooctane sulfonic acid results in increased expression of POU5F1 mRNA, perfluorooctane sulfonic acid results in increased expression of POU5F1 protein CTD PMID:25510869 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1552733 6480464 perfluorooctane sulfonic acid affects the expression of POU5F1 protein CTD PMID:28288859 phenanthrene multiple interactions ISO RGD:1552733 6480464 phenanthrene affects the reaction [Tretinoin results in decreased expression of POU5F1 protein] CTD PMID:21111795 phenanthrene decreases expression ISO RGD:1552733 6480464 phenanthrene results in decreased expression of POU5F1 protein CTD PMID:21111795 phenol red increases expression ISO RGD:1350605 6480464 Phenolsulfonphthalein results in increased expression of POU5F1 mRNA CTD PMID:22132214 piperonyl butoxide multiple interactions ISO RGD:1552733 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of POU5F1 gene CTD PMID:23968726 poly(I:C) multiple interactions ISO RGD:1350605 6480464 Poly I-C promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein] CTD PMID:29486283 poly(I:C) increases expression ISO RGD:1350605 6480464 Poly I-C results in increased expression of POU5F1 protein CTD PMID:29486283 progesterone multiple interactions ISO RGD:1350605 6480464 [Progesterone co-treated with Estradiol] results in increased expression of POU5F1 mRNA CTD PMID:17404688 quercetin decreases expression ISO RGD:1350605 6480464 Quercetin results in decreased expression of POU5F1 protein CTD PMID:22422628 quinpirole decreases expression ISO RGD:1350605 6480464 Quinpirole results in decreased expression of POU5F1 mRNA CTD PMID:27920206 quinpirole multiple interactions ISO RGD:1350605 6480464 DRD2 protein promotes the reaction [Quinpirole results in decreased expression of POU5F1 mRNA] CTD PMID:27920206 resveratrol decreases expression ISO RGD:1350605 6480464 resveratrol results in decreased expression of POU5F1 mRNA, resveratrol results in decreased expression of POU5F1 protein CTD PMID:21304978 , PMID:22692956 resveratrol multiple interactions ISO RGD:1350605 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of POU5F1 mRNA CTD PMID:23557933 rotenone multiple interactions ISO RGD:1350605 6480464 Rotenone inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 saquinavir multiple interactions ISO RGD:1552733 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of POU5F1 mRNA CTD PMID:16931933 SB 203580 multiple interactions ISO RGD:1350605 6480464 SB 203580 inhibits the reaction [(1R more ... CTD PMID:24607276 SB 431542 multiple interactions ISO RGD:1350605 6480464 [4-(5-benzo(1 more ... CTD PMID:32949729 , PMID:34480604 sepantronium decreases expression ISO RGD:1350605 6480464 sepantronium results in decreased expression of POU5F1 protein CTD PMID:28787001 silicon dioxide increases expression ISO RGD:1350605 6480464 Silicon Dioxide analog results in increased expression of POU5F1 mRNA CTD PMID:25895662 sirolimus increases expression ISO RGD:1552733 6480464 Sirolimus results in increased expression of POU5F1 mRNA, Sirolimus results in increased expression of POU5F1 protein CTD PMID:21681844 sodium arsenite multiple interactions ISO RGD:1552733 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with sodium arsenite] results in decreased expression of POU5F1 protein more ... CTD PMID:23143138 , PMID:26438402 sodium arsenite increases expression ISO RGD:1350605 6480464 sodium arsenite results in increased expression of POU5F1 mRNA, sodium arsenite results in increased expression of POU5F1 protein CTD PMID:26735578 more ... sodium arsenite decreases expression ISO RGD:1350605 6480464 sodium arsenite results in decreased expression of POU5F1 mRNA CTD PMID:19615344 sodium arsenite affects expression ISO RGD:1350605 6480464 sodium arsenite affects the expression of POU5F1, sodium arsenite affects the expression of POU5F1 mRNA CTD PMID:20056578 , PMID:23052196 sodium arsenite multiple interactions ISO RGD:1350605 6480464 MALAT1 mRNA promotes the reaction [sodium arsenite results in increased expression of POU5F1 mRNA] more ... CTD PMID:19615344 more ... sodium arsenite decreases expression ISO RGD:1552733 6480464 sodium arsenite results in decreased expression of POU5F1 protein CTD PMID:23143138 sodium arsenite affects expression ISO RGD:1552733 6480464 sodium arsenite affects the expression of POU5F1 mRNA, sodium arsenite affects the expression of POU5F1 protein CTD PMID:26438402 , PMID:28370166 SR9243 decreases expression ISO RGD:1350605 6480464 SR9243 results in decreased expression of POU5F1 protein CTD PMID:31932555 streptozocin multiple interactions EXP 6480464 [bisphenol A co-treated with Streptozocin] results in decreased expression of POU5F1 protein CTD PMID:35187753 SU6656 decreases expression ISO RGD:1350605 6480464 SU 6656 results in decreased expression of POU5F1 protein CTD PMID:23527294 tamoxifen decreases expression ISO RGD:1350605 6480464 Tamoxifen results in decreased expression of POU5F1 protein CTD PMID:22906706 Tanshinone I increases expression ISO RGD:1552733 6480464 tanshinone results in increased expression of POU5F1 mRNA CTD PMID:25186638 Tanshinone I multiple interactions EXP 6480464 tanshinone inhibits the reaction [Estrogens deficiency results in decreased expression of POU5F1 protein] CTD PMID:31108107 taurocholic acid increases expression ISO RGD:1552733 6480464 Taurocholic Acid results in increased expression of POU5F1 mRNA CTD PMID:27151938 testosterone increases expression ISO RGD:1350605 6480464 Testosterone results in increased expression of POU5F1 mRNA CTD PMID:34719554 tetrachloromethane decreases expression ISO RGD:1552733 6480464 Carbon Tetrachloride results in decreased expression of POU5F1 mRNA CTD PMID:31919559 thymoquinone decreases expression ISO RGD:1350605 6480464 thymoquinone results in decreased expression of POU5F1 protein CTD PMID:31298468 titanium dioxide increases expression ISO RGD:1552733 6480464 titanium dioxide results in increased expression of POU5F1 mRNA CTD PMID:23557971 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of POU5F1 gene CTD PMID:27618143 trichostatin A multiple interactions ISO RGD:1350605 6480464 trichostatin A promotes the reaction [decitabine affects the expression of POU5F1 mRNA] CTD PMID:18440631 trichostatin A increases expression ISO RGD:1350605 6480464 trichostatin A results in increased expression of POU5F1 mRNA CTD PMID:22723015 , PMID:26272509 triclosan decreases expression ISO RGD:1552733 6480464 Triclosan results in decreased expression of POU5F1 mRNA, Triclosan results in decreased expression of POU5F1 protein CTD PMID:24879426 triptonide increases expression ISO RGD:1552733 6480464 triptonide results in increased expression of POU5F1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1350605 6480464 tris(2-butoxyethyl) phosphate affects the expression of POU5F1 mRNA CTD PMID:29024780 tubocurarine decreases expression ISO RGD:1552733 6480464 Tubocurarine results in decreased expression of POU5F1 mRNA CTD PMID:15612475 tubocurarine multiple interactions ISO RGD:1552733 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of POU5F1 mRNA] CTD PMID:15749260 valproic acid multiple interactions ISO RGD:1552733 6480464 [Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of POU5F1 mRNA CTD PMID:27693483 valproic acid decreases expression ISO RGD:1350605 6480464 Valproic Acid results in decreased expression of POU5F1 mRNA, Valproic Acid results in decreased expression of POU5F1 protein CTD PMID:29775723 , PMID:34742744 valproic acid decreases expression ISO RGD:1552733 6480464 Valproic Acid results in decreased expression of POU5F1 mRNA CTD PMID:27237783 valproic acid multiple interactions ISO RGD:1350605 6480464 Valproic Acid inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] CTD PMID:32949729 valproic acid increases expression ISO RGD:1350605 6480464 Valproic Acid results in increased expression of POU5F1 mRNA CTD PMID:22723015 more ... valproic acid affects expression ISO RGD:1552733 6480464 Valproic Acid affects the expression of POU5F1 mRNA CTD PMID:27693483 verapamil multiple interactions ISO RGD:1350605 6480464 [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 mRNA, [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 protein CTD PMID:35063459 XAV939 multiple interactions ISO RGD:1350605 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mRNA CTD PMID:34480604 zidovudine multiple interactions ISO RGD:1552733 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of POU5F1 mRNA more ... CTD PMID:16931933
